Transforming Patient Care with Molecular Testing: Current and Future Impacts

  • Credit:1.5 ACCENT Credits
  • Duration: 2 hrs
  • Date:JUL.28.2015 5:30 PM - 07:30 PM

Price: $0.00

Member Price: $0.00

Rating: Member Average

At this free educational event, you will hear three distinguished speakers share their clinical experiences in the screening and diagnosis of cervical cancer and the role of molecular testing in achieving greater accuracy and confidence in the results.

The speakers will also present their perspectives on how the lab can consult and partner with clinicians to further integrate molecular testing into clinical care to achieve improved patient outcomes.

Register today for what promises to be a highly educational and engaging event!

This educational activity has been made possible by an educational grant from Roche Diagnostics.

Target Audience

Laboratory administrators, directors, managers and medical technologists; clinical pathologists

Learning objectives

  • Describe examples of how clinicians are currently utilizing molecular diagnostics in their patient care practices.
  • Describe the benefits and challenges experienced by clinicians to interpret molecular test data and accurately apply to patient care.   
  • Describe how lab can support clinicians to increase their understanding and further implement molecular testing into clinical care. 


Mark Stoler                        
Mark Stoler, MD, FASCP

Lee Shulman
Lee Shulman, MD, FACMG, FACOG

catherine behrens
Catherine Behrens, MD, PhD, FACOG

Program Schedule

5:30 to 5:45 pm                    
Arrival and Check-in

5:45 to 5:50 pm                     
Welcome Remarks

Alan Wright, MD, MPH
Chief Medical Officer
Roche Diagnostics

5:50 – 5:55 pm                       
Moderator Introductions

Glen Hansen, PhD
Hennepin County Medical Center, Minneapolis, MN

5:55 – 6:15 pm                       
How HPV Diagnostics and Biomarkers are Improving the Practice of Anatomic Pathology Today

Mark Stoler, MD, FASCP
Professor (Emeritus) of Pathology, Cytology and Gynecology
Director, Gynecological Pathology Fellowship Program
University of Virginia, Charlottesville, VA

6:15 – 6:35 pm                       
Evolution of Cervical Cancer Screening

Lee Shulman, MD, FACMG, FACOG
Chief, Division of Obstetrics and Gynecology-Clinical Genetics
Professor, Obstetrics and Gynecology
Northwestern University Medicine, Chicago, IL

6:35 – 6:55 pm                       
A Clinician’s Perspective on Improving Cervical Screening With Molecular Testing
Catherine M. Behrens, MD, PhD, FACOG
Consultant, Roche Molecular Systems, San Francisco, CA                                      

6:55 – 7:10 pm                       
Q&A and Panel Discussion

7:10 pm              
Adjournment of Educational Event

7:10 – 7:30 pm                       
Social and Networking Reception

Continuing Education Credits

AACC designates this live activity for a maximum of 1.0 ACCENT® credit hours towards the AACC Clinical Chemist’s Recognition Award. AACC is an approved provider of continuing education (CE) for clinical laboratory scientists licensed in states that require documentation of CE, including California, Florida, Louisiana, Montana, Nevada, North Dakota, Rhode Island, Tennessee, and West Virginia. ACCENT® credit is also recognized by several organizations: AAB, ABCC, ACS, AMT, ASCLS, ASCP, ASM, CAP, IFCC, and NRCC.

Program location

This event will be held in the International Ballroom North at the Hyatt Regency Atlanta Hotel.

Hyatt Regency Atlanta
265 Peachtree St NE
Atlanta, GA, 30303

Take shuttle bus #3 (Green) from the Georgia World Congress Center to get to the Hyatt Regency Atlanta Hotel.

Supported By

Abbott Diagnostics 

Roche 2014 Logo